Skip to main content

Table 2 Comparison of the survival rates for ICRT VS ICCCRT

From: Induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus volumetric modulated arc therapy alone in the treatment of stage II-IVB nasopharyngeal carcinoma patients: a retrospective controlled study

Variable ICRT arm ICCCRT arm
OS (%)
 At 3-years 79.1 86.1
 At 5-years 57.5 47.8
PFS (%)
 At 3-years 64.7 80.5
 At 5-years 41.8 38.4
  1. ICRT induction chemotherapy plus radiotherapy, ICCCRT concurrent chemotherapy plus radiotherapy